FDA panel considers ban on electric stimulation devices for aversion therapy

  • April 24, 2014

Today the FDA Neurological Devices Panel convened to consider a ban on electric stimulation devices for aversive conditioning in patients inflicting self-harm and displaying aggressive behavior. Though the panel made no decision today, it stated that its primary concern is the safety and wellbeing of patients receiving this therapy and recognized the need for clinical trials to examine the benefits and risks of electric stimulation devices in these patients.

Panel member Wayne K. Goodman, MD, chair of the department of psychiatry at Mount Sinai Hospital, stated that though many patients have seen benefits from this treatment he is “not ready to say we should disseminate this treatment to others.”

Full Story »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!

  • Meeting News Coverage
  • OSN meeting
  • ASCRS 2014
  • Live onsite coverage from the Ophthalmology Innovation Summit and the American Society of Cataract and Refractive Surgeons annual meeting in Boston will begin on Thursday, April 24.
  • Human microbiome
  • microbiome 4_25_14
  • A 'How To' Guide
  • A trio of researchers authors “how to” guide for gastroenterologists navigating the rapidly expanding field of human microbiome research.
More »
More »
  • SLIT agents are trending
  • Sublingual immunotherapy
  • Healio.com presents the latest in sublingual immunotherapy FDA and research news.
More »
More »
  • Health Care Update
  • Medicare lab payments
  • New law will modernize Medicare lab payments: What physicians need to know. Analysis from Arnold & Porter LLP.
More »